A recent long-COVID paper, “Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome”, was given some prominence by Medscape. The authors focused on the presence of postural orthostatic tachycardia syndrome (POTS) in long...
A riff on Dr. Peter Rowe’s presentation at the 2020 Dysautonomia International Conference (note that I expand on many of Rowe’s points; i.e. not all the words are his.) Lauren Stiles, the founder of Dysautonomia International, has long believed that the...
Autoimmune autonomic ganglionopathy is a very rare disease. So why feature it in a blog on chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and postural orthostatic tachycardia syndrome (POTS)? Because it could provide a preview of the future. All these diseases...
The Paradox An earlier blog focused on the “renin-aldosterone paradox” in chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS). The renin-angiotensin-aldosterone system (RAAS) regulates blood volume and a whole bunch of...
The first of two of three blogs exploring the renin-angiotensin-aldosterone system in ME/CFS and COVID-19. Warning – this blog is complex… Back in 1997, they had a couple of important things right – orthostatic intolerance (OI) is basically caused by...
The two Dutch researchers, C. Linda van Campen and Frans Visser, and Peter Rowe from the U.S., have been on a tear recently. The Van Campen/Visser team (mostly with Peter Rowe) have published 6 ME/CFS studies thus far in 2020, one in 2019 and three in 2018. This is...
